SynopsisNon-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the live.....
SynopsisThe global Celiac Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Celiac Disease in various end use industries. The expanding demands from th.....
SynopsisMass Gainer supplement are high in calories and have various levels of fat, protein, carbohydrates, vitamins, minerals, amino acids and other nutrients. A mass gainer is high in fats and carbohydrates than protein. Gainer Protein is taken to increase the calor.....
SynopsisEszopiclone, marketed by Sunovion under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia. The global Eszopiclone Drug market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 115 million b.....
SynopsisRecombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade. The global Recombinant Human Coagulation VIIa market.....
SynopsisLong-acting beta-agonists or long-acting beta adrenergic receptor agonists are class of drugs used in the management of asthma by relaxing the muscles surrounding the bronchial tubes and facilitating the opening the airways wider. Long-acting beta-agonists hav.....
SynopsisMulti dose drug vial adapters are adapters designed with vials or small containers to allow withdrawal of more than on dose of the vial contents. The global Multi Dose Drug Vial Adapter market was valued at US$ million in 2023 and is anticipated to reach.....
SynopsisIt is a therapeutic device. High-intensity focused ultrasound is used. The global Coagulation Ultrasound Surgical Unit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast pe.....
SynopsisButorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and hor.....
SynopsisAtenolol, is a medication of the beta blockers type, primarily used to treat high blood pressure and angina. The global Atenolol Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % dur.....
